Marché des lasers ophtalmologiques au Moyen-Orient et en Afrique – Tendances et prévisions de l’industrie jusqu’en 2030

Analyse et perspectives du marché des lasers ophtalmologiques au Moyen-Orient et en Afrique

Le marché des lasers ophtalmologiques au Moyen-Orient et en Afrique devrait croître au cours de la période de prévision de 2023 à 2030. Data Bridge Market Research analyse que le marché croît avec un TCAC de 4,4 % au cours de la période de prévision de 2023 à 2030 et devrait atteindre 136,75 millions USD d'ici 2030 contre 97,10 millions USD en 2022.

Ce rapport sur le marché des lasers ophtalmologiques fournit des détails sur les nouveaux développements récents, les réglementations commerciales, l'analyse des importations et des exportations, l'analyse de la production, l'optimisation de la chaîne de valeur, la part de marché, l'impact des acteurs du marché national et localisé, les opportunités d'analyse en termes de poches de revenus émergentes, les changements dans la réglementation du marché, l'analyse stratégique de la croissance du marché, la taille du marché, la croissance du marché des catégories, les niches d'application et la domination, les approbations de produits, les lancements de produits, les expansions géographiques, les innovations technologiques sur le marché. Pour obtenir plus d'informations sur le marché des lasers ophtalmologiques, contactez Data Bridge Market Research pour un briefing d'analyste. Notre équipe vous aidera à prendre une décision de marché éclairée pour atteindre la croissance du marché.

Définition du marché

Les lasers ophtalmologiques sont des dispositifs médicaux spécialisés qui émettent des faisceaux de lumière focalisés pour traiter diverses affections oculaires. Ces lasers sont couramment utilisés en ophtalmologie pour effectuer diverses procédures, telles que le traitement des troubles de la vision, la correction des erreurs de réfraction et la gestion de diverses maladies oculaires. Ces appareils ont gagné en importance et en adoption en raison de la forte prévalence de plusieurs maladies ophtalmiques, telles que le glaucome , la cataracte et d'autres problèmes liés à la vision.

Dynamique du marché des lasers ophtalmologiques au Moyen-Orient et en Afrique

 This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:

Drivers

• Increasing incidences of chronic and communicable eye diseases

The field of ophthalmology has seen a rise in the incidence of both chronic and communicable eye diseases in recent years. Some of the major factors contributing to this trend include a growing Middle East and Africa population, an aging population, increased urbanization, changing lifestyles, and increased exposure to environmental pollutants. One of the most common chronic eye diseases is Age-Related Macular Degeneration (AMD). AMD is a leading cause of blindness in people over the age of 60 and is caused by damage to the macula, a small part of the retina responsible for central vision. The prevalence of AMD is expected to increase with an aging Middle East and Africa population. Another chronic eye disease that is becoming more prevalent is glaucoma. Glaucoma is a group of eye diseases that cause damage to the optic nerve and can lead to blindness. It is often asymptomatic until it reaches an advanced stage, making regular eye exams crucial for early detection and treatment.

In March 2023, according to an article by Indian Express, Middle East and Africa, glaucoma is the second leading cause of blindness after cataracts. It is estimated to cause blindness in 4.5 million people worldwide. Despite this, glaucoma is largely undiagnosed, with more than 90 percent of untreated cases. Thus, increasing incidences of chronic and communicable eye diseases are expected to drive the market's growth.

• Increased consumer awareness for laser treatments

Consumer awareness of laser therapies has increased, which has benefited the market for ophthalmic lasers Middle East and Africa. Several factors have contributed to this trend, including advancements in technology, increased access to information, and greater emphasis on patient education. One of the main drivers of increased consumer awareness is the development of new laser systems that offer improved precision, reduced recovery times, and better outcomes. These systems have been shown to be effective in treating a range of eye conditions, from refractive errors to more complex retinal disorders. Patients are increasingly interested in these treatments and are seeking out ophthalmologists who are trained to use them. Another factor contributing to increased awareness is the availability of information about ophthalmology lasers. Patients can easily access information online about the different types of laser treatments available, their benefits, and potential risks. This has helped to demystify laser treatments and make them more accessible to a wider range of patients which is expected to drive the market's growth.

• Increasing adoption of outpatient procedures

The field of ophthalmology has seen significant advancements in recent years with the advent of laser technology. With the increasing adoption of outpatient procedures, the Middle East and Africa ophthalmology lasers market presents a significant opportunity for growth. Outpatient procedures are medical procedures that do not require an overnight stay in a hospital. These procedures can be performed in a medical office, ambulatory surgery center, or outpatient clinic. Thus, the increasing adoption of outpatient procedures is expected to drive the market's growth.

Opportunities

• Technological advancements in ophthalmology

Technological advancements in the field of ophthalmology have revolutionized the diagnosis, treatment, and management of various eye diseases and conditions. These advancements have created significant opportunities in the Middle East and Africa ophthalmology lasers market, with the potential to improve patient outcomes, increase efficiency, and drive growth in the industry. One of the most significant technological advancements in ophthalmology has been the development of femtosecond lasers. These lasers are used for precision surgeries and can create incisions that are more precise and predictable than those created by traditional surgical tools. This technology has revolutionized procedures such as photocoagulation lasers, Selective Laser Trabeculoplasty (SLT), allowing for faster recovery times and better visual outcomes, which is expected to provide a lucrative opportunity for the market's growth.

Restraints/Challenges

• Lack of skilled professionals

Ophthalmology lasers are used in various procedures, including refractive surgeries, cataract surgeries, and glaucoma treatment. However, the effective use of these lasers requires skilled professionals who are proficient in handling them. The lack of such professionals can lead to errors, complications, and adverse outcomes, which can harm patients and damage the industry's reputation.

The main reason for the shortage of skilled professionals is the complexity of the equipment and the procedures involved. Ophthalmology lasers require specialized knowledge and expertise, and the training required to become proficient in using them can be time-consuming and expensive. In addition, the procedures themselves are often intricate and require a high level of skill and precision

Hence, a lack of skilled professionals will impede the growth rate of the ophthalmology lasers market. Additionally, stringent rules and regulations will further challenge the market in the forecast period.

Recent Development

• In November 2022, Alcon, the Middle East and Africa leader in eye care dedicated to helping people see brilliantly, announced that it had completed its acquisition of Aerie Pharmaceuticals, Inc. This transaction helps bolster Alcon's presence in the ophthalmic pharmaceutical space with its growing portfolio of commercial products and development pipeline.
• In March 2023, Bausch + Lomb Corporation and Novaliq GmbH announced that the American Journal of Ophthalmology had published results from MOJAVE, the second pivotal Phase 3 trial for NOV03 (perfluorohexyloctane). NOV03 is being investigated to treat the signs and symptoms of Dry Eye Disease (DED) associated with Meibomian Gland Dysfunction (MGD). Results from the first pivotal Phase 3 trial, GOBI, were published earlier this year in the American Journal of Ophthalmology.

Middle East and Africa Ophthalmology Lasers Market Scope

The Middle East and Africa ophthalmology lasers market is segmented into product, type, application, gases, and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Product

• Femtosecond Lasers
• Excimer Lasers
• Nd: YAG Lasers
• Diode Lasers
• Others

On the basis of product, the market is segmented into femtosecond lasers, excimer lasers, Nd: YAG lasers, diode lasers, and others.

Type

• Photodisruption Lasers
• Selective Laser Trabeculoplasty (SLT)
• Photocoagulation Lasers

On the basis of type, the market is segmented into photodisruption lasers, selective laser trabeculoplasty (SLT), and photocoagulation lasers.

Application

• Diagnostics
• Therapeutics

On the basis of application, the market is segmented into diagnostics and therapeutics.

Gases

• Noble gas
• Halogen gas
• Buffer gas
• Others

On the basis of gases, the market is segmented into noble gas, halogen gas, buffer gas, and others.

End User

• Hospitals
• Clinics
• Others

On the basis of end user, the market is segmented into hospitals, clinics, and others.

Middle East and Africa Ophthalmology Lasers Market Regional Analysis/Insights    

The Middle East and Africa ophthalmology lasers market is analyzed, and market size insights and trends are provided by country, product, type, application, gases, and end user, as referenced above.

The countries covered in the Middle East and Africa ophthalmology lasers market are South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and the Rest of the Middle East and Africa.

South Africa is expected to dominate the Middle East and Africa ophthalmology lasers market due to the high prevalence of ophthalmic disorders in the region and rapid research development.

The country section of the report also provides individual market-impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, disease epidemiology, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of Middle East and Africa brands and their challenges faced due to high competition from local and domestic brands and the impact of sales channels are considered while providing forecast analysis of the country data.

Analyse du paysage concurrentiel et des parts de marché des lasers ophtalmologiques au Moyen-Orient et en Afrique

Le paysage concurrentiel du marché des lasers ophtalmologiques au Moyen-Orient et en Afrique fournit des détails par concurrents. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence au Moyen-Orient et en Afrique, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit et la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises sur le marché des lasers ophtalmologiques au Moyen-Orient et en Afrique.

Certains des principaux acteurs opérant sur le marché des lasers ophtalmologiques au Moyen-Orient et en Afrique sont NIDEK CO., LTD., Quantel Medical (une filiale de Lumibird Medical), Alcon, Johnson & Johnson Inc., Bausch & Lomb Incorporated, MEDA Co., Ltd., Topcon, Lumenis Be Ltd., IRIDEX Corporation et Zeiss, entre autres.

SKU-69950